BridgeBio Pharma, Inc.
BBIO
$76.08
$1.321.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.40% | 60.04% | -9.05% | -14.66% | 40.01% |
| Total Receivables | 24.00% | 47.17% | 19.68% | 51.58% | -33.31% |
| Inventory | 60.22% | 23.28% | 9.08% | 34.20% | 362.24% |
| Prepaid Expenses | 8.32% | 48.27% | -18.89% | -13.70% | 70.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -33.63% | 5.31% | 12.42% | -6.04% | 65.81% |
| Total Current Assets | -11.94% | 55.60% | -4.96% | -7.99% | 31.23% |
|
|
|||||
| Total Current Assets | -11.94% | 55.60% | -4.96% | -7.99% | 31.23% |
| Net Property, Plant & Equipment | 0.62% | 64.02% | 9.14% | 0.73% | -11.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.62% | -2.56% | -2.49% | -2.43% | 6.15% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.06% | 11.42% | -34.52% | 40.97% | 9.01% |
| Total Assets | -11.21% | 46.47% | -6.23% | -7.59% | 22.52% |
|
|
|||||
| Total Accounts Payable | -6.39% | -19.79% | 93.71% | -28.44% | -5.05% |
| Total Accrued Expenses | 33.74% | -3.81% | 29.88% | 41.28% | 25.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.12% | 8,813.47% | 16.96% | 10.71% | -8.20% |
| Total Finance Division Other Current Liabilities | -9.30% | -14.95% | -20.88% | -39.58% | -6.70% |
| Total Other Current Liabilities | -9.30% | -14.95% | -20.88% | -39.58% | -6.70% |
| Total Current Liabilities | 9.10% | 183.49% | 32.95% | 23.17% | 15.61% |
|
|
|||||
| Total Current Liabilities | 9.10% | 183.49% | 32.95% | 23.17% | 15.61% |
| Long-Term Debt | 0.34% | 51.00% | -31.06% | 45.29% | 0.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.32% | 273.03% | 11.21% | -14.86% | -18.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -11.17% | -98.62% | 6,187.86% | -98.33% | 60.95% |
| Total Liabilities | 2.29% | 20.82% | 3.14% | 2.18% | 13.42% |
|
|
|||||
| Common Stock & APIC | 2.03% | 2.66% | 1.95% | 1.89% | 2.19% |
| Retained Earnings | -3.82% | -4.29% | -5.32% | -5.30% | -5.57% |
| Treasury Stock & Other | -31.42% | -25.53% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -10.40% | -9.19% | -7.94% | -8.12% | -8.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.40% | -9.19% | -7.94% | -8.12% | -8.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.75% | -5.39% | -3.02% | 9.53% | -2.97% |
| Total Equity | -10.45% | -9.26% | -8.00% | -8.11% | -8.53% |
|
|
|||||